Immunostimulation by Complete Freund's Adjuvant, Granulocyte Macrophage Colony-Stimulating Factor, or Interferon-γ Reduces Severity of Diabetic Embryopathy in ICR Mice

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 70, Issue 1, 2004, Pages 20-27

  Punareewattana, Korawuth ^a   Holladay, Steven D ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STREPTOZOCIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC EMBRYOPATHY; DISEASE SEVERITY; EMBRYOPATHY; FEMALE; FETUS MALFORMATION; HYPERGLYCEMIA; IMMUNOSTIMULATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; TERATOGENESIS;

ABNORMALITIES; ADJUVANTS, IMMUNOLOGIC; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FREUND'S ADJUVANT; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON TYPE II; MALE; MICE; MICE, INBRED ICR; PREGNANCY; PREGNANCY IN DIABETICS;

CELL FUSING AGENT VIRUS;

EID: 1042289688     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10137     Document Type: Article

References (43)

1. Ashkar AA, Di Santo JP, Croy BA. 2000. Interferon-γ contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 17:259-269.
2. Baker L, Piddington R, Goldman A. 1986. Myo-inositol and arachidonic acid are linked in the mechanism of diabetic embryopathy. Diabetes 35(Suppl 1):12A.
3. Fein A, Kostina E, Savion S, et al. 2001. Expression of tumor necrosis factor-α in the pregnant uterus of diabetic mice: effect of maternal immunostimulation. Am J Reprod Immunol 46:161-168.
4. Flynn A, Finke JH, Hilfiker ML. 1982. Placental mononuclear phagocytes as a source of interleukin-1. Science 218:475-477.
5. Goldman AS, Baker L, Piddington R, et al. 1985. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci USA 82:8227-8231.
6. Gorivodsky M, Torchinsky A, Zemliak I, et al. 1999. TGFβ2 mRNA expression and pregnancy failure in mice. Am J Reprod Immunol 42:124-133.
7. Gorivodsky M, Zemlyak I, Orenstein H, et al. 1998. TNF-alpha messenger RNA and protein expression in the uteroplacental unit of mice with pregnancy loss. J Immunol 160:4280-4288.
8. Guan Z, Buckman SY, Miller BW, et al. 1998. Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J Biol Chem 273:28670-28676.
9. Guimond MJ, Wang B, Croy BA. 1998. Engraftment of bone marrow from severe combined immunodeficiency (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J Exp Med 187:217-223.
10. Haddad EK, Duclos AJ, Lapp WS, Baines MG. 1997. Early embryo loss is associated with the prior expression of macrophage activation markers in the decidua. J Immunol 158:4886-4892.
11. Head JR. 1996-97. Uterine natural killer cells during pregnancy in rodents. [Review]. Nat Immun 15:7-21.
12. Hill JR, Corbett JA, Kwon G, et al. 1996. Nitric oxide regulates interleukin 1 bioactivity released from murine macrophages. J Biol Chem 271:22672-22678.
13. Hill JR, Kwon G, Marshall CA, McDaniel ML. 1998. Hyperglycemic levels of glucose inhibit interleukin 1 release from RAW 264.7 murine macrophages by activation of protein kinase C. J Biol Chem 273:3308-3313.
14. Holladay SD, Sharova LV, Smith BJ, et al. 2000. Non-specific stimulation of the maternal immune system. I. Reduced teratogen-induced fetal malformations. Teratology 62:420-428.
15. Holladay SD, Sharova, LV, Punareewattana K, et al. 2002. Maternal immune stimulation in mice decreases fetal malformations caused by teratogens. Int Immunopharmacol 2:325-332.
16. Hunt JS, Petroff MG, Burnett TG. 2000. Uterine leukocytes: key players in pregnancy. Semin Cell Dev Biol 11:127-137.
17. Hunt JS, Robertson SA. 1996. Uterine macrophages and environmental programming for pregnancy success. J Reprod Immunol 32:1-25.
18. Ivnitsky I, Torchinsky A, Gorivodsky M, et al. 1998. TNF-α expression in embryos exposed to a teratogen. Am J Reprod Immunol 40:431-440.
19. Lakey JRT, Singh B, Warnock GL, Rajotte RV. 1994. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic nod mice. Transplantation 57:1213-1217.
20. Letterio JJ, Geiser AG, Kulkarni AB, et al. 1994. Maternal rescue of transforming growth factor-&BGR;1 null mice. Science 264:1936-1938.
21. Lim H, Paria BC, Das SK, et al. 1997. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91:197-208.
22. Morohoshi M, Fujisawa K, Uchimura I, Numano F. 1996. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45:954-959.
23. Nomura T, Hata S, Kusafuka T. 1990. Suppression of developmental anomalies by maternal macrophages in mice. J Exp Med 172:1325-1330.
24. Pampfer S, Vanderheyden I, McCracken JE, et al. 1997. Increased cell death in rat blastocysts exposed to maternal diabetes in utero and to high glucose or tumor necrosis factor-α in vitro. Development 124:4827-4836.
25. Pampfer S. 2001. Dysregulation of the cytokine network in the uterus of the diabetic rat. Am J Reprod Immunol 45:375-381.
26. Pinter E, Reece EA, Leranth CZ, et al. 1986. Arachidonic acid prevents hyperglycemia associated yolk sac damage and embryopathy. Am J Obstet Gynecol 155:691-702.
27. Rauk PN, Chiao JP. 2000. Interleukin-1 stimulates human uterine prostaglandin production through induction of cyclooxygenase-2 expression. Am J Reprod Immunol 43:152-159.
28. Reece EA. 1999. Maternal fuels, diabetic embryopathy: pathomechanisms and prevention. Semin Reprod Endocrinol 17:183-194.
29. Robertson SA, O'Connell AC, Hudson SN, Seamark RF. 2000. Granulocyte-macrophage colony-stimulating factor (GM-CSF) targets myeloid leukocytes in the uterus during the post-mating inflammatory response in mice. J Reprod Immunol 46:131-154.
30. Robertson SA, Seamark RF, Guilbert LJ, Wegmann TG. 1994. The role of cytokines in gestation. Crit Rev Immunol 14:239-292.
31. Sacks G, Sargent I, Redman C. 1999. An innate view of human pregnancy. Immunol Today 20:114-118.
32. Sadelain MWJ, Qin H-Y, Lauzon J, Singh B. 1990. Prevention of type 1 diabetes in nod mice by adjuvant immunotherapy. Diabetes 39:583-589.
33. Sharova L, Sura P, Smith BJ, et al. 2000. Nonspecific stimulation of the maternal immune system. II. Effects on gene expression in the fetus. Teratology 62:420-428.
34. Sharova LV, Gogal RM, Jr, Sharov AA, et al. 2002. Immune stimulation in urethane-exposed pregnant mice causes increased expression of genes for cytokines, including TGFβ and GM-CSF, that have previously been suggested as possible mediators of reduced birth defects. Int Immunopharmacol 2:1477-1489.
35. Sharova LV, Sharov AA, Sura P, et al. 2003. Maternal immune stimulation reduces both placental morphologic damage and down-regulated placental growth factor and cell cycle gene expression caused by urethane: Are these events related to reduced teratogenesis? Int Immunopharm 3:945-955.
36. Siman CM, Eriksson UJ. 1997. Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia 40:1416-1424.
37. Sivan E, Reece EA, Wu YK, et al. 1996. Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol 175:793-799.
38. Strassburger D, Carp H, Toder V. 1992. Immune reproductive failure: Effect of non-specific immunostimulation in mouse model. Am J Reprod Immunol 28:274-276.
39. Toder V, Strassburger D, Irlin Y, et al, 1990. Nonspecific immunopotentiators and pregnancy loss: complete Freund's adjuvant reverses high fetal resorption rate in CBA x DBA/2 mouse combination. Am J Reprod Immunol 24:63-66.
40. Torchinsky A, Toder V, Savion J, et al. 1997. Immunostimulation increases the resistance of mouse embryos to the teratogenic effect of diabetes mellitus. Diabetologia 40:635-640.
41. 2 levels in rat embryos exposed to a diabetic environment. Diabetes 48:813-820.
42. Wiznitzer A, Aylon N, Hershkovitz R, et al. 1999. Lipoic acid prevention of neural tube defects in offspring of rats with streptozotocin-induced diabetes. Am J Obstet Gynecol 180:188-193.
43. Yitzhakie D, Torchinsky A, Savion S, Toder V. 1999. Maternal immunopotentiation affects the teratogenic response to hyperthermia. J Reprod Immunol 45:49-66.